SPIRIT FIRST
This article was originally published in The Gray Sheet
Executive Summary
First patient receives Guidant's Multi-Link Vision everolimus-eluting stent in prospective, randomized, single-blind, 60-subject feasibility study. Conducted at four sites in The Netherlands and Germany, the trial will compare in-stent late loss with the uncoated Multi-Link Vision at six months (1"The Gray Sheet" Nov. 24, 2003, p. 9)...